The Calmer Co is a health and wellness company focussing on kava and other natural products that promote calmness, support mind and muscle relaxation and improve sleep.
Products are delivered to consumers as functional beverages, drinking powders, capsules, teas, shots and concentrates under 3 brands, Fiji Kava, Taki Mai and Danodan Hempworks.
The company sells direct to consumers online in Australia, USA, China and the Pacific islands in addition to growing blue chip retail partnerships with Coles, Amazon and Walmart.com.
The Calmer Co has recently launched kava shots under its Taki Mai brand into Australian Coles supermarkets. It is the only business exporting green kava shots to international markets.
In addition to kava, the business is developing a CBD division under its Danodan Hempworks brand as a range of organic hemp flower infusions and CBD oils. With its central processing facility based in Navua, The Calmer Co has a supply chain spanning 10 major Fijian provinces and involving more than 10,000 kava farmers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
Online sales of Calmer Co wellness products surpasses 10k per day for March
Health & Biotech
The Calmer Co rides wave of rising kava demand as younger generations ditch alcohol
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps and IPO Weekly Wrap: The week we learned what Woolies is really worth
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX phones in more gains as prices plunge in Beijing and records tumble in New York
News
Rise and Shine: Everything you need to know before the ASX opens
News
In Case You Missed It: Tim Goyder’s new speccy gets drilling, BHP doles out the $$
News
Top 10 at 10: It’s a big BHP cash splash
News
Top 10 at 11: It’s all pearls, primates, Parkinson’s and potash as far as the eye can see today
News
In Case You Missed It: A Chilean silver mine and $1m worth of lithium rights
News
Market Highlights: OPEC+ to cut supply, home prices at record highs again, and 5 ASX small caps to watch
Health & Biotech
China’s Silk Road for health and wellness is now even more of a two-way street with Australia
Health & Biotech
Once banned in Australia, kava’s demand could go global according to ASX-listed The Calmer Co
News
ASX Earnings Wrap: Siteminder surges 20pc on solid hotel bookings; Prospa swings to loss and tanks 12pc
News
Closing Bell: ASX 200 finishes week with a red day, but at least a sand stock (PEC) is well up
News